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Abstract
Background: The Norwegian Board of Health Supervision aims to contribute to the improvement of quality and
patient safety in the healthcare services. Planned audits were performed to investigate how 12 selected Norwegian
obstetric units reported and analyzed adverse events as the part of their quality assurance and patient safety work.
Methods: Serious adverse events coded as birth asphyxia, shoulder dystocia and severe postpartum hemorrhage
that occurred during 2014 (the most recent year for which the quality assured data were available) were obtained
from the Medical Birth Registry of Norway. The obstetric units were asked to submit medical records, internal
adverse events reports, and their internal guidelines outlining which events should be reported to the quality
assurance system. We identified the adverse events at each obstetric unit that were reported internally and/or to
the central authorities. Two obstetricians carried out an evaluation of each event reported.
Results: Five hundred fifty-three serious adverse events were registered among 17,323 births that took place at the
selected units. Twenty-one events were excluded because of incorrect coding or missing information. Eight events
were registered in more than one category, and these were distributed to the category directly related to injury or
adverse outcome. Nine of twelve (75 %) obstetric units had written guidelines describing which events should be
reported. The obstetric units reported 49 of 524 (9.3 %) serious adverse events in their internal quality assurance
system and 39 (7.4 %) to central authorities. Of the very serious adverse events, 29 of 149 (19.4 %) were reported.
Twenty-three of 49 (47 %) reports did not contain relevant assessments or proposals for improving quality and
patient safety.
Conclusions: This study showed that adverse event reporting and analyses by Norwegian obstetric units, as a part
of quality assurance and patient safety work, are suboptimal. The reporting culture and compliance with guidelines
need to be improved substantially for better safety in patient care, risk mitigation and clinical quality assurance.
Keywords: Supervision, Adverse event, Asphyxia, Shoulder dystocia, Postpartum hemorrhage, Reporting culture,
Obstetric care unit, Failure of treatment.
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Background
Good quality healthcare services should provide health
benefits, be safe and take care of users’ wishes and needs
[1]. This also applies in maternity care where the mother
or child may get injured as a result of malpractice and
substandard care [2]. There are several factors that can
contribute to improving quality in obstetric care. Health-
care professionals must possess appropriate knowledge,
skills and attitude, as well as keep their competencies
up-to-date through continuous learning and practical
skills training. In this way, they will be able to efficiently
manage emergencies and appropriately handle adverse
events. They must also be able to work in teams and
communicate clearly. Leaders in obstetric units have a
responsibility to ensure that professional and
organizational guidelines are developed, revised and
made known to the health personnel engaged in patient
care. Finally, it is important to establish a culture of
transparently reporting and learning from serious ad-
verse events [3–6].
In the recent years, healthcare systems in many coun-
tries, including Norway, have increased their focus on
quality assurance and patient safety. Some have imple-
mented patient safety programs to reduce the number of
adverse events [7, 8]. Clinical leaders have a special re-
sponsibility to build a culture of patient safety that can
help strengthen and improve services [9].
Several countries have established sanction-free
reporting systems in line with recommendations from
the WHO (www.who.int) and the Council of Europe
(www.coe.int). Some have national reporting systems,
whereas others rely on local or regional ones. Some
countries have voluntary notification systems (USA,
New Zealand, Denmark) and in others this may be re-
quired by law (Norway, Sweden). There may also be dif-
ferent criteria as to what is mandatory in terms of
reporting. Denmark (www.stps.dk) and England (www.
england.nhs.uk) have established systematic reporting at
a national level.
There are few international studies dealing with the
reporting of serious events in obstetric care. A study
from New Zealand showed a significant underreporting
of adverse events, where a mother or child died or was
injured, to quality registers [10]. In the UK, a national
reporting system for adverse events was established in
2003 (NRLS), but the data related to obstetric care show
that the events are not always correctly reported [11].
In Norway, it is mandatory to report all births to the
Medical Birth Registry of Norway (MBRN). In addition,
legislation requires the reporting of serious events to the
central authorities. A review of supervisory cases that in-
cluded serious adverse events in obstetric care showed
that only 39.1 % of the events were reported by the ob-
stetric units [2].
Adverse events should be reviewed and analyzed by
every single unit, to see if routines and practices should be
changed. This is regarded as an important part of quality
assurance and patient safety work in Norway (the Special-
ist Health Services Act § 3-4a and the Health Care Super-
vision Act § 3). In 2012, the reporting system to central
authorities was changed so that the notifications were to
be sent to a sanction-free authority, the Norwegian Direct-
orate of Health (Specialist Health Services Act § 3–3). At
the same time, a scheme was introduced where the most
serious events (deaths and very serious injuries) were to
be notified to The Norwegian Board of Health Supervision
(NBHS), a governmental supervisory authority for child
welfare, health and social services in Norway (Specialist
Health Services Act § 3-3a).
Causal analyses following adverse events should try to
provide answers to: what happened, why it happened,
and what can be done to prevent similar events from
happening again. Retrospective analyses within other
sectors, e.g. aviation, have been used for decades, but are
now also implemented after adverse events in the health
service. In the USA, UK and Denmark, hospitals must
carry out such an analysis in the wake of adverse events
[12, 13]. Risk analyses have attracted increasing research
interest, also in obstetrics [13–15].
Several studies, in which the quality of obstetric prac-
tice has been assessed, have been based on serious
events that were reported to supervisory authorities, pa-
tient injury systems, or processed in the judicial system
[11, 16, 17]. These represent selected material that, to a
small extent, describe the scope of adverse events and
how often they are reported internally or to central
authorities.
We hypothesized that although they comprise an im-
portant part of quality assurance and patient safety work,
only a small proportion of adverse events are reported
or analyzed by obstetric units. The aim of this study was
to investigate whether adverse events in obstetric care
were reported to central authorities or just to the obstet-
ric unit’s own internal quality assurance and adverse
event reporting system. We also wanted to see if the
events reported internally were analyzed and assessed
adequately by the obstetric units’ own quality and safety
councils and if there were differences among small,
medium and large obstetric units. In addition, we
wanted to analyze if there was a difference in the num-
ber of events reported by the obstetric units that the
supervisory authorities considered as high-risk and se-
lected for closer surveillance, compared to the other
units.
Methods
This study is based on data collected by NBHS, by the
authority of its supervisory mandate, during inspections
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of 12 selected obstetric units in Norway looking at three
categories (birth asphyxia, shoulder dystocia and severe
postpartum hemorrhage) of serious adverse obstetric
events. These three categories are known to be associ-
ated with a substantial risk of serious adverse outcome
for the mother or child. The inspection process, data
collection and validation have been reported previously
[18]. The study period was limited to include reported
cases occurring between January 1 and December 31
2014, as the data from this year were the latest that were
quality assured by the MBRN. The total number of ob-
stetric units in Norway at this time was 49 (31 with <
1000 births per year, 11 with 1000–1999 births per year,
and seven with ≥ 2000 births per year). Six of the units
were chosen because the supervisory authorities had sus-
pected that the obstetric care delivered at these units
was potentially high-risk, and that there was an indica-
tion to survey their routines and practices. This risk as-
sessment was based on the experiences gathered from
previous inspections. Another six units were chosen ran-
domly for comparison. In total, we evaluated six obstet-
ric units with < 1000 births per year (small), four units
with 1000–1999 births per year (medium) and two units
with ≥ 2000 births per year (large).
The three categories of serious adverse events were
chosen according to the following criteria as described
previously [18]:
1) Birth asphyxia: singleton birth during which the
baby died in utero after the mother’s admission to
the obstetric unit, during birth, during the first 6
days after birth, or the infant had an Apgar score of
< 7 after 5 min of birth and needed to be
transferred to the neonatal intensive care unit.
2) Shoulder dystocia: vaginal singleton birth with
difficult delivery of the shoulder and the newborn
requiring admission to the neonatal intensive care
unit or the infant with confirmed brachial plexus
injury or fracture of humerus and/or clavicle.
3) Severe postpartum hemorrhage (PPH): vaginal
singleton birth during which the mother bled more
than 1500 millilitre (mL) within 24 h of birth and/
or received blood transfusion.
Events with neonatal Apgar score < 5 after 5 min of
birth, brachial plexus injuries or fractures, and
hemorrhage ≥ 2500 mL, were defined as very serious ad-
verse events.
On July 6, 2016, the NBHS requested information
from the MBRN regarding the number of adverse events
in these three categories of adverse events (birth as-
phyxia, shoulder dystocia, severe PPH) reported by each
of the 12 obstetric units during the study period, based
on the criteria described above.
Multiple pregnancies, births occurring before 36 weeks
of gestation, and neonates with malformations (struc-
tural or chromosomal) were excluded.
On November 30, 2016, the NBHS requested copies of
medical records of the cases from all 12 obstetrics units,
along with the journal entries by midwives and obstetri-
cians regarding the course of labor and delivery, as well
as the reports from their own evaluation of the adverse
events. In addition, we requested the institutions’ local
guidelines regarding when and how to report adverse
events.
All 12 obstetric units responded to the inquiry. Eleven
units responded by January 6, 2017. The last unit replied
on June 2, 2017, after a reminder.
The results were registered in a database designed for
this study. For each adverse event, the obstetric unit,
type of the event and method of delivery were recorded.
We registered events reported to central authorities as
well as those evaluated by the obstetric units locally.
Two of the authors (L.T.J., P.Ø.), both senior consultant
obstetricians, evaluated these reports. We evaluated
whether the obstetric care was in accordance with stand-
ard clinical practice, based on Norwegian obstetric
guidelines and international literature [19]. This evalu-
ation was carried out independently by the two obstetri-
cians. In case of discrepancy, a final decision was made
after discussion. After completion of the audit, all the
obstetric units that were evaluated received a detailed re-
port on their own performance and recommendations
from the NBHS regarding areas requiring
improvements.
Data analysis was performed using IBM SPSS Statistics
version 26.0. Quantitative data were grouped according
to the size of the obstetric units and comparisons were
made between the groups using chi-squared test. A p-
value of < 0.05 was considered significant.
Results
The prevalence of adverse events and the rate of occur-
rence of substandard care within each category of events
in this study population have been reported previously
[18]. The MBRN registered 553 serious adverse events
within the three categories studied, among 17,323 deliv-
eries in the 12 obstetric units. Twenty-one cases were
excluded from analysis (incorrectly coded diagnosis in
10 cases and incomplete medical records in 11 cases).
The cases (n = 8) that had the adverse events registered
in more than one category were assigned to the category
directly related to the injury or adverse outcome. Thus,
a total of 524 cases with adverse events were included in
the final analysis. The prevalence of adverse events
within the categories evaluated was 3 %, of which 19.7 %
(n = 103) had birth asphyxia, 11.4 % (n = 60) had
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shoulder dystocia or brachial plexus injury, and 68.9 %
(n = 361) had severe PPH.
Nine (5.5 %) of 163 neonates died during or shortly
after birth, 161 (98.7 %) neonates had to be treated in
neonatal intensive care, and 33 (20.2 %) had a brachial
plexus injury or fracture of humerus and/or clavicle. Of
the 361 women who had severe PPH, 254 (70.3 %) had
blood transfusion and 145 (40.1 %) had a prolonged hos-
pital stay (> 3 days after vaginal birth).
According to the medical records 221 (42.1 %) patients
received information about the birth process from a doc-
tor or midwife, 112 (21.3 %) received a call or were ex-
amined again after discharge. It was further documented
that seven (1.3 %) patients were informed about health
care failure and five (0.9 %) about the possibility of ap-
plying for financial compensation from The Norwegian
System of Compensation to Patients (NPE).
The obstetric units reported internally 27 of 112
(26 %) events with birth asphyxia, five of 60 (8.3 %)
events with shoulder dystocia and brachial plexus injury,
17 of 361 (4.7 %) events with severe PPH. A total of 49
of 524 (9.3 %) events with serious adverse events, and 29
of 149 (19.4 %) of those with a very serious adverse
events were reported in the internal quality assurance
and adverse event reporting system. Table 1 shows the
total number of adverse events and how many of them
were reported internally in small, medium-sized and
large obstetric care units. There were statistically signifi-
cant differences between the three groups of obstetric
care units.
Table 2 shows the number of adverse events with very
serious adverse events and how many of them were re-
ported in the internal quality assurance and adverse
event reporting system. There were statistically signifi-
cant differences between the obstetric units grouped by
size.
The number of adverse events that were reported to
central authorities pursuant to the Specialist Health
Services Act § 3–3 was a total of 39 (7.4 %), including a
total of eight (1.5 %) according to the Specialist Health
Services Act § 3-3a.
Table 3 shows the number of adverse events reported
by the 12 obstetric units in their internal quality assur-
ance system divided into two groups; six units selected
by the supervisory authorities as high-risk for closer sur-
veillance and six randomly selected units (control
group). There were no statistically significant differences
in the number (%) of reported events in the two groups.
We assessed all 49 adverse events reported to the in-
ternal quality assurance and adverse event reporting sys-
tem that were analyzed locally. In our assessment, the
analyses were relevant in 26 (53.0 %) events. In the
remaining 23 (47.0 %), there was insufficient information
about the events in the report, the assessment of the
birth process was inadequate, and/or what measures
should be implemented to improve the quality of care
and patient safety was not described.
Nine of 12 obstetric care units (75.0 %) had written
guidelines describing which events were to be reported,
but only four of 12 (33.3 %) had described how the re-
ports were to be processed and followed up.
Discussion
In this study, we found that the obstetric units in
Norway reported less than 10 % of adverse events with
birth asphyxia, shoulder dystocia or severe postpartum
hemorrhage in their own internal quality assurance and
adverse event reporting system, and only 7.4 % were re-
ported further to the central authorities. Less than one
fifth of the very serious events were reported. It is worry-
ing that even in a highly developed, high-income country
with a national universal healthcare insurance coverage,
a patient injury compensation system and sanction-free
mandatory reporting required by law, so few events are
reported and analyzed as part of quality assurance and
patient safety work. As transparent reporting and
Table 1 Number of adverse events (birth asphyxia, shoulder dystocia, severe postpartum hemorrhage) obtained from the Medical
Birth Registry of Norway and events reported in the internal quality assurance and adverse event reporting system of obstetric units
according to their size (small < 1000 births per year, medium 1000–1999 births per year, large ≥ 2000 births per year) in 12
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8489 264 31.09 (264/8489) 14 1.64 (14/8489) 5.27 (1,64/31.09)
Chi-square test: χ2 = 11,9, df = 2, p = 0.002
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appropriate analyses of adverse events is a prerequisite
for learning, risk management and preventing patient in-
juries, improving reporting culture is essential. In
addition to laws and government directives, better edu-
cation and training of healthcare professionals in patient
safety and risk management, as well as improving aware-
ness and providing incentives for transparent reporting,
may be required to motivate and engage them in clinical
quality assurance.
In this study, we wanted to take a closer look at ser-
ious adverse clinical events. An adverse event is usually
defined as an accidental injury to the patient that occurs
in connection with medical/surgical treatment. The in-
jury can have different levels of severity such as death,
permanent disability or extended hospital stay [20]. The
supervisory authorities wanted to assess events that fell
into these categories. They obtained information from
MBRN on the number of patients who had birth as-
phyxia, shoulder dystocia or severe postpartum
hemorrhage and verified events reported by evaluating
the medical records of the patients in question from
each obstetric care unit. To our knowledge, no studies
with a similar design have previously been reported. The
method had advantages since we were able to obtain in-
formation on all the serious clinical adverse events in
each category.
Our study showed that only a very small fraction of se-
vere adverse obstetric events was reported internally and
to the central authorities, although the majority of these
events should have been reported, either because there
was a patient injury or because the events could have led
to serious injury (cf. the Specialist Health Services Act,
Chap. 3). The purpose of the notification scheme is for
the healthcare institutions to learn from adverse events.
Therefore, especially in the case of events where there
was a failure, these should have been reported, reviewed
and analyzed. We have previously shown that there was
a failure in diagnoses and treatment in 56.2 % of the
events in this material, but no significant differences
were observed between small, medium and large birth
units [18]. In that study, we also found that a greater
number of adverse events occurred in the control group,
rather than in the maternity units considered to be at
high-risk by the supervisory authorities. The supervisory
authorities´ assessments of which units to consider as
high-risk should be based on several parameters, not
only on their experiences from previous inspections.
According to Norwegian law, these events should have
been reported, but the text of the law is open to a cer-
tain discretionary assessment of whether the events must
be reported or not. It is important to note that most ob-
stetric care units (75 %) had their own guidelines for
Table 2 Number of very serious adverse events (death or asphyxia with Apgar < 5 after 5 min, brachial plexus injury or fracture of
clavicle/humerus, postpartum hemorrhage ≥2500 mL) obtained from the Medical Birth Registry of Norway and reported in the
internal quality assurance and adverse event reporting system of obstetric units according to their size (small < 1000 births per year,
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5907 52 8.80 (52/5907) 18 3.04 (18/5907) 34.54 (3.04/8.80)
>2000 births
per year
8489 83 9.77 (83/8489) 9 1.06 (9/8489) 10.84 (1.06/9.77)
Chi-square test: χ2 = 11,8, df = 2, p = 0.003
Table 3 Number of obstetric adverse events (birth asphyxia, shoulder dystocia, severe postpartum hemorrhage) obtained from the
Medical Birth Registry of Norway and events reported and analyzed in the internal quality assurance and adverse event reporting
system in 12 Norwegian obstetric units in 2014, grouped into those selected by the supervisory authorities for a closer surveillance
(n = 6 units) and those randomly allocated to a control group (n = 6 units). Chi-squared test with Yates correction
Type of maternity unit Total number of
births at term
Total number of
adverse events, n (%)
Adverse events
reported, n (%)
Number of adverse events with
adequate assessment, n (%)
Six maternity units selected by the
supervisory authorities as high-risk
7720 215 (2.78) 15 (6.97) 6 (40.00 %)
Six maternity units allocated randomly
as a control group
9603 309 (3.21) 32 (10.35) 17 (53.12 %)
Chi2, df 2.7324, 1 2.5609, 1 2.4781, 1
p-value > 0.10 > 0.10 > 0.10
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what events that should be reported. However, we have
previously shown that the guidelines are not followed to
a great extent [18, 21]. Furthermore, even among the
very serious adverse events, which should have been re-
ported in accordance with Norwegian law (Specialist
Health Services Act §§ 3–3 and 3-3a) and national
guidelines [19], less than one fifth were reported. Thus,
there was significant under-reporting, and our findings
are in concordance with other studies [22–24].
The survey also shows that there are statistically sig-
nificant differences in reporting frequency between dif-
ferent sized obstetric units. It is striking that the
reporting frequency seems to be highest in the medium-
sized units. However, our study design does not make it
possible to deduce any information about the reasons
for these differences. Nevertheless, it might be reason-
able to assume that the differences are related to the in-
stitutions’ organizational culture and clinical governance.
The secondary aim of our current study also was to
evaluate if there were differences in reporting of adverse
events between units selected by the supervisory author-
ities for closer surveillance and those randomly allocated
as a control group. There were no significant differences
between the two groups. This may indicate that the size
of the obstetric units had the greatest significance for
whether serious adverse events were reported, not the
units considered as high-risk.
In Norway, anonymized reporting was introduced in
2012, which led to an increase in the number of events
reported to central authorities [25]. However, our find-
ings show that there are still many adverse obstetric
events that are not reported. The data, which central au-
thorities receive through the reporting schemes, there-
fore provide little information about the extent of
adverse events in obstetric care and the types of events
that occur [10, 11]. Several measures are needed to en-
sure that adverse events are reported correctly, transpar-
ently and comprehensively. Healthcare personnel must
not only be familiar with the legal text that describes
what needs to be reported, but must also know and fol-
low the national guidelines from the professional society
of obstetrics and gynecology [19].
Several studies have shown an underreporting of ad-
verse events [22], including in obstetric units [2, 10, 23].
There may be several reasons for underreporting. The
units that do not have a traditional culture of reporting
and learning from serious events are less likely to have
midwives and obstetricians reporting serious events [22].
Some obstetricians fail to report because they feel guilt or
shame, others because they fear punishment [24]. It has
been shown that reporting culture may be different among
different healthcare professionals. Midwives seem to re-
port adverse events more often than doctors, although
often these are events without serious injury [26].
In our study, less than half of the reports contained
relevant assessments and analyses of the adverse
events or suggestions for improvements. In Norway,
the incidents are assessed by the hospital’s quality as-
surance council. Members of this council consists of
different healthcare professionals who are not always
familiar with obstetric assessments. In our opinion, it
was possible to make adequate assessment of the inci-
dents if all information available in the medical rec-
ord had been assessed by health personnel with the
right competence.
According to Norwegian law, patients or relatives must
receive information (Patient and User Rights Act § 3 − 2)
about adverse events: what happened and what measures
can be taken to prevent similar events from happening
again. In addition, they must be informed about the possi-
bility of applying for financial compensation. Our review
of medical records showed that less than half received in-
formation about the birth process and only 0.9 % were in-
formed about the possibility of applying for financial
compensation to the Norwegian System of Compensation
to Patients (NPE), a government agency under the Minis-
try of Health and Care Services (https://www.npe.no/en/).
However, as our findings were based on the information
obtained from medical records, it is not possible to rule
out that this information was provided without being re-
corded. Sound information and good communication,
which also mentions failures, help to create and build trust
in health professionals. At the same time, it can help to fa-
cilitate the patients’ own processing of a traumatic birth
process [27].
Strengths and limitations
The strength of our study is that the information
from MBRN made it possible to get a comprehen-
sive overview of all adverse events in the three cat-
egories studied in each obstetric unit. The
implementation of a planned inspection by to the
Norwegian Board of Health Supervision ensured
that all patient records and non-conformance re-
ports were sent to the supervising authority. The
weakness of the study is that the material is rela-
tively small, especially the number of very serious
adverse events. This means that the statistical ana-
lyses must be interpreted with caution. The data are
from 2014, and may not reflect the current situation
in Norway as there might have been changes in rou-
tines and practices regarding which incidents are to
be reported and analyzed.
Conclusions
This study shows that adverse event reporting by
Norwegian obstetric units, as a part of quality assur-
ance and patient safety work, is suboptimal. As
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transparent reporting and analyses of serious ad-
verse events is crucial for learning risk management
and preventing adverse events, reporting culture and
compliance with guidelines need to be improved
substantially for better safety in patient care, risk




LTJ: Conception and design of the study, project management, data
collection, analysis and interpretation of data and main responsibility for
drafting the manuscript. GSB: Analysis and interpretation of data, writing/
editing the manuscript. GA: Interpretation of data, writing/editing and
proofreading the manuscript. JFA: Interpretation of data, writing/editing the
manuscript. PØ: Conception and design of the study, project management,
analysis and interpretation of data, drafting and editing the manuscript. The
authors read and approved the final manuscript.
Funding
No specific funding was obtained from external sources.
Availability of data and materials
The data that support the findings of this study are available from The
Norwegian Board of Health Supervision (NBHS), but restrictions apply to the
availability of these data, which were used under license for the current
study, and so are not publicly available. Anonymized data can, however, be
made available with the permission of NBHS by the corresponding author
upon reasonable request.
Declarations
Ethics approval and consent to participate
The study was carried out as a regulatory audit, thus as a part of the annual
working plan of The Norwegian Board of Health Supervision (NBHS). The
legal basis for evaluating the data is the Health Care Supervision Act, and the
Health Research Act does not affect this project. A request was forwarded to
the Regional Committee for Medical and Health Research Ethics (REK), and
the conclusion was that the project was not obliged by law to obtain a
separate ethical approval (reference 2016/1500B). All data were treated and





Authors have no competing interest to declare in relation to this article.
Author details
1Department for Specialized Health Services, Norwegian Board of Health
Supervision, PO Box 231 Skøyen, 0213 Oslo, Norway. 2Stavanger University
Hospital, Stavanger, Norway. 3Western Norway University of Applied
Sciences, Sogndal, Norway. 4Women’s Health and Perinatology Research
Group, Department of Clinical Medicine, UiT-The Arctic University of Norway,
Tromsø, Norway. 5Department of Obstetrics and Gynecology, University
Hospital of North Norway, Tromsø, Norway. 6Division of Obstetrics and
Gynecology, Department of Clinical Science, Intervention and Technology,
Karolinska Institute and Center for Fetal Medicine, Department of Women’s
Health, Karolinska University Hospital, Stockholm, Sweden.
Received: 21 April 2021 Accepted: 25 August 2021
References
1. World Health Organization (WHO). Quality of care. 2021. https://www.who.
int/health-topics/quality-of-care#tab=tab_(07.01.21)
2. Johansen LT, Braut GS, Andresen JF, Øian P. An evaluation by the
Norwegian Health Care Supervision Authorities of event involving death or
injuries in maternity care. AOGS. 2018;97:1206–1211.
3. Forskrift om ledelse og kvalitetsforbedring i helse- og omsorgstjenesten
(Regulation on managment and quality improvement in health and care
service). In Norwegian. Lovdata 2016. https://lovdata.no/dokument/LTI/
forskrift/2016-10-28-1250 (07 Jan 2021)
4. Berglund S. "Every case of asphyxia can be used as a learning example”.
Conclusions from an analysis of substandard obstetrical care. J Perinat Med.
2011;40:9–18.
5. Nystrøm M, Westerlund A, Høøg E, Millde-Luthander C, Høgberg U,
Grunewald C. Healthcare system intervention for prevention of birth injuries
- process evaluation of self-assessment, peer review, feedback and
agreement for change. BMC Health Serv Res. 2012;12:274.
6. Rankin J, Bush J, Bell R, Cresswell P, Renwick M. Impacts of participating in
confidential enquiry panels: a qualitative study. BJOG. 2006;113:387–92.
7. WHO Safe Childbirth Checklist. 2015. https://www.who.int/patientsafety/
topics/safe-childbirth/childbirth-checklist/en/ (16 March 2020)
8. Helsedirektoratet 2014. I trygge hender 24 – 7. The Norwegian Directorate
of Health. In safe hands. In Norwegian. Oslo. https://pasientsikkerhetsprogra
mmet.no/om-oss/om-pasientsikkerhetsprogrammet/i-trygge-hender-24-7
(16 March 2020)
9. Dixon-Woods M, Baker R, Charles K, Dawson J, Jerzembek G, Martin G, et al.
Culture and behavior in English National Health Service: overview of lessons
from a large multimethod study. BMJ Qual Saf. 2014;23(2):106–15.
10. Farquhar C, Armstrong S, Kim B, Masson V, Sadler L. Under-reporting of
maternal and perinatal adverse events in New Zealand. BMJ Open. 2015;
5(7):e007970.
11. Howell AM, Burns EM, Bouras G, Donaldson LJ, Athanasiou T, Darzi A. Can
patient safety incident reports be used to compare hospital safety? Results
from a quantitative analysis of the English national reporting and learning
system data. PLoS One. 2015;10:e0144107.
12. Card AJ, Ward J, Clarkson PJ. Successful risk assessment may not always lead
to successful risk control: a systematic literature review of risk control after
root cause analysis. J Healthc Risk Manag. 2012;31:6–12.
13. Taitz J, Genn K, Brooks V, Ross D, et al. System-wide learning from root
cause analysis: a report from the New South Wales Root Cause Analysis
Review Committee. BMJ Qual Saf Health Care. 2010;19:1–5.
14. University of Oxford. Oxford 2018. MBRRACE-UK Perinatal Mortality
Surveillance report for births in 2016. https://www.npeu.ox.ac.uk/mbrrace-
uk/reports (04 July 2018)
15. Penney G, Brace V. Near miss audit in obstetrics. Curr Opin Obstet Gynecol.
2007;19:145–150.
16. Andreasen S, Backe B, Jørstad RG, Øian P. A nationwide descriptive study of
obstetric claims for compensation in Norway. Acta Obstet Gynecol Scand.
2012;91:1191–5.
17. Ten Years of Maternity Claims - An Analysis of NHS Litigation Authority Data
- october 2012. NHS Litigation Authority. 2013. https://resolution.nhs.uk/wp-
content/uploads/2018/11/Ten-years-of-Maternity-Claims-Final-Reportfinal-2.
pdf. (6 sept 2021).
18. Johansen LT, Braut GS, Acharya G, Andresen JF, Øian P. How common is
substandard obstetric care in events of birth asphyxia, shoulder dystocia
and postpartum hemorrhage – findings from an external inspection of
Norwegian maternity units. AOGS. 2021;100:139–46.
19. Norsk gynekologisk forening. Veileder i fødselshjelp 2014. [Norwegian
gynecological association. Guide to childbirth 2014, (National guidelines in
obstetrics)]. Oslo. In Norwegian. https://www.legeforeningen.no/
foreningsledd/fagmed/norsk-gynekologisk-forening/veiledere/veileder-i-
fodselshjelp (15 Jan 21)
20. Vincent C, editor. Patient Safety. 2nd ed. Oxford: Wiley; 2010. p. 52–6.
21. Steer PJ. We know how to write Guidelines, now we need to implement
them. BJOG. 2020;127:477.
22. Blais R, Bruno D, Barlett G, Tamblyn R. Can we use incident reports to detect
hospital adverse events? J Patient Saf. 2008;4(1):9–12.
23. Johansen LT, Øian P. Neonatal deaths and injuries. Tidsskr Nor Laegeforen.
2011;131:2465–8.
24. Stanhope N, Chrowley-Murphy M, Vincent C, Connor AM, Taylor-Adams SE.
An evaluation of adverse incident reporting. J Eval Clin Pract. 1999;5:5–12.
25. SINTEF 2014. Evaluering av meldeordningen om uønskede hendelser i
spesialisthelsetjensten. Evaluation of the reporting scheme for adverse
events in the specialist health service. Oslo. In Norwegian. (https://www.
Johansen et al. BMC Health Services Research          (2021) 21:931 Page 7 of 8
sintef.no/globalassets/sintef-teknologi-og-samfunn/rapporter-sintef-ts/
sintef-a26547_sluttrapport_meldeordning.pdf
26. Rowin EJ, Lucier D, Pauker SG. Does error and adverse event reporting
by physicians and nurses differ. Jt Comm J Qual Patient Saf. 2008;34:
537–43.
27. Pronovost PJ, Miller MR, Wachter RM. Tracking progress in patient safety: an
elusive target. JAMA. 2006;296:696–99.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Johansen et al. BMC Health Services Research          (2021) 21:931 Page 8 of 8
